0       0

Neonatal Pharmacology


FRI300 - Pharmacologic Management of Pulmonary Hypertension in BPD (Rx = .75 hr.)


Apr 20, 2018 3:00pm ‐ Apr 20, 2018 3:45pm

Expiration Date: May 21, 2021


Credits: None available.

Standard: $9.00

Description

Learning Objectives:

  • Evaluate supportive therapy in infants with pulmonary hypertension secondary to bronchopulmonary dysplasia, including diuretic and corticosteroid therapy
  • Describe available therapies for a pulmonary hypertensive crisis in an infant with bronchopulmonary dysplasia, including inhaled nitric oxide and milrinone
  • Design an algorithm for chronic pulmonary vasodilation in a neonate with pulmonary hypertension secondary to bronchopulmonary dysplasia, including sildenafil, bosentan, and inhaled prostanoids

Speaker(s):

Credits

  • 0.75 - Pharmacology
  • 0.75 - Physician
  • 0.75 - RN / NP (All RNs/Nurses except CA RNs)
  • 0.90 - CA RN/CA BRN
  • 0.75 - Pharmacist

You must be logged in and own this session in order to post comments.

Brenda Frankfort
5/5/18 8:31 pm

The info presented is what is practices at my facility

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content